Insights On CONTRACT PHARMA MANUFACTURING
-
60-Seconds Of Science: Optimizing Complex Molecule Production
2/20/2026
A principal scientist shares how his team overcame key manufacturing challenges in complex bispecific antibody production, highlighting problem-solving strategies and impressive results in this concise educational video.
-
60-Seconds Of Science
2/20/2026
Explore the complex biologics journey, featuring expert-led discussions on development, analytics, MSAT, and tech transfer, offering concise, practical insights for busy professionals worldwide.
-
Advancing ADCs With Expertise In Payloads And Linkers
2/18/2026
Discover how integrated containment, high-potency expertise, advanced chromatography, and proven linker–payload process optimization can accelerate your ADC program from early development to reliable commercial supply.
-
MS/MS For Confident Sialic Acid ID
2/18/2026
MS/MS distinguishes isobaric sialic acids to confirm safe glycan structures, reduce immunogenic risk, and boost confidence in late‑stage biologics before review.
-
How To Fast-Track Your Oral Solid Dose To Phase 1
2/17/2026
A strategic approach accelerates oral solid dose development by uniting molecular analysis, solubility improvement, formulation design, manufacturing efficiency, and stability testing to reach Phase 1 faster.
-
Practical USP <1665>/<665> Guide To E&L Risk Assessment
2/17/2026
A practical USP <1665> and <665> framework helps manufacturers evaluate and manage extractables and leachables risk, supporting quality, safety, and regulatory compliance.
-
Monitoring, Media Fills, And QC: Demonstrating Sterility Assurance At Your CDMO
2/13/2026
CDMO guide on environmental monitoring, media fills, and QC to prove sterility assurance in aseptic manufacturing—key elements of the Contamination Control Strategy beyond facility design.
-
EU Annex 1: Building Modern CDMO Sterile Fill/Finish Facilities
2/13/2026
A CDMO guide to implementing EU Annex 1 for modern sterile fill/finish facilities, covering cleanroom design, contamination control, utilities, personnel, monitoring, and audit essentials.
-
The Adenovirus Revolution In Cancer Treatment
2/13/2026
Adenoviruses are being reimagined as powerful tools for oncolytic cancer therapy, using their immunogenicity, tumor selectivity, and synergy with immunotherapy to drive new clinical progress.
-
Beyond Solid Phase Synthesis
2/12/2026
Explore how enzymatic methods, real-time analytics, and AI optimization enhance long-sequence TIDES, improving control, speeding timelines, and supporting sustainable production.